Shanghai Pharmaceuticals Holding Co Ltd (601607) — Cash Flow Quality Index
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Cash Flow Quality Index of 2.26x as of September 2025. Operating cash flow of CN¥1.56 Billion exceeds net income of CN¥688.20 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Pharmaceuticals Holding Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Pharmaceuticals Holding Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Shanghai Pharmaceuticals Holding Co Ltd across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shanghai Pharmaceuticals Holding Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Shanghai Pharmaceuticals Holding Co Ltd. For live market cap and the full company financial profile, see Shanghai Pharmaceuticals Holding Co Ltd (601607) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.08x | CN¥6.15 Billion | CN¥5.72 Billion | ▲ +8.3% |
| 2024 | 0.99x | CN¥5.83 Billion | CN¥5.87 Billion | ▼ -28.5% |
| 2023 | 1.39x | CN¥5.23 Billion | CN¥3.77 Billion | ▲ +104.7% |
| 2022 | 0.68x | CN¥4.74 Billion | CN¥6.99 Billion | ▼ -15.9% |
| 2021 | 0.81x | CN¥5.06 Billion | CN¥6.27 Billion | ▼ -33.9% |
| 2020 | 1.22x | CN¥6.84 Billion | CN¥5.61 Billion | ▼ -2.0% |
| 2019 | 1.25x | CN¥6.02 Billion | CN¥4.83 Billion | ▲ +77.2% |
| 2018 | 0.70x | CN¥3.14 Billion | CN¥4.46 Billion | ▲ +7.8% |
| 2017 | 0.65x | CN¥2.65 Billion | CN¥4.06 Billion | ▲ +28.4% |
| 2016 | 0.51x | CN¥1.95 Billion | CN¥3.83 Billion | ▲ +26.8% |
| 2015 | 0.40x | CN¥1.35 Billion | CN¥3.36 Billion | ▼ -10.2% |
| 2014 | 0.45x | CN¥1.34 Billion | CN¥2.99 Billion | ▲ +20.5% |
| 2013 | 0.37x | CN¥973.45 Million | CN¥2.63 Billion | ▼ -20.8% |
| 2012 | 0.47x | CN¥1.15 Billion | CN¥2.46 Billion | ▼ -35.5% |
| 2011 | 0.72x | CN¥1.77 Billion | CN¥2.45 Billion | ▼ -23.5% |
| 2010 | 0.95x | CN¥1.69 Billion | CN¥1.78 Billion | ▼ -62.4% |
| 2009 | 2.52x | CN¥664.13 Million | CN¥263.48 Million | ▲ +14.2% |
| 2008 | 2.21x | CN¥285.68 Million | CN¥129.43 Million | ▼ -56.9% |
| 2007 | 5.12x | CN¥488.94 Million | CN¥95.48 Million | ▼ -20.5% |
| 2006 | 6.44x | CN¥583.11 Million | CN¥90.54 Million | ▲ +529.9% |
| 2005 | 1.02x | CN¥73.00 Million | CN¥71.40 Million | ▲ +129.7% |
| 2004 | 0.45x | CN¥61.66 Million | CN¥138.51 Million | ▲ +18973.7% |
| 2003 | 0.00x | CN¥484.27K | CN¥207.48 Million | ▼ -99.6% |
| 2002 | 0.62x | CN¥100.84 Million | CN¥163.07 Million | ▲ +64.4% |
| 2001 | 0.38x | CN¥65.73 Million | CN¥174.77 Million | ▼ -47.4% |
| 2000 | 0.71x | CN¥146.22 Million | CN¥204.65 Million | ▼ -51.9% |
| 1999 | 1.49x | CN¥164.67 Million | CN¥110.84 Million | ▲ +147.1% |
| 1998 | -3.15x | CN¥-283.14 Million | CN¥89.83 Million | — |